A carregar...
Doubling down on PKC benefits allogeneic BMT
In this issue of Blood, using genetically deficient donor T cells or posttransplant pharmacologic inhibition, Haarberg et al have conclusively demonstrated that protein kinase C (PKC)-θ and PKC-α each contribute to alloreactivity after experimental allogeneic bone marrow transplantation (BMT).(1)
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3790501/ https://ncbi.nlm.nih.gov/pubmed/24092926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-08-519900 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|